Price

rebased to 0%

PRME, solidAMGN, dashed

PRMEPrime Medicine, Inc.

4.44−6.04%· post 4.44· delayed

Mkt cap—Revenue$1MQ2 FY26Revenue$5MFY25

AMGNAmgen Inc

465.45−0.12%· post 466.80· delayed

After hoursNov 2 '26delayed

Mkt cap$251.9BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

vs

Compare

After hoursNov 2 '26delayed

PRMEPrime Medicine, Inc.

vs

AMGNAmgen Inc

4.44−6.04%post 4.44delayed

Price

465.45−0.12%post 466.80delayed

—

Mkt cap

$251.9B

Q2 FY26$1M

Revenue

$10.1BQ2 FY26

FY25$5M

Revenue

$36.8BFY25

PRME compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name